Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/1999

01-05-1999

Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors

Authors: Sylvie Ménard, Patrizia Casalini, Gorana Tomasic, Silvana Pilotti, Natale Cascinelli, Rosaria Bufalino, Franco Perrone, Chiara Longhi, Franco Rilke, M. Ines Colnaghi

Published in: Breast Cancer Research and Treatment | Issue 2/1999

Login to get access
Metadata
Title
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviors
Authors
Sylvie Ménard
Patrizia Casalini
Gorana Tomasic
Silvana Pilotti
Natale Cascinelli
Rosaria Bufalino
Franco Perrone
Chiara Longhi
Franco Rilke
M. Ines Colnaghi
Publication date
01-05-1999
Publisher
Kluwer Academic Publishers
Published in
Breast Cancer Research and Treatment / Issue 2/1999
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1023/A:1006262324959

Other articles of this Issue 2/1999

Breast Cancer Research and Treatment 2/1999 Go to the issue

OriginalPaper

Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT‐B

OriginalPaper

Synergistic action of apoptosis induced by eicosapentaenoic acid and TNP‐470 on human breast cancer cells

OriginalPaper

Differentially expressed genes associated with the metastatic phenotype in breast cancer

OriginalPaper

Cathepsin D expression by cancer and stromal cells in breast cancer: an immunohistochemical study of 1348 cases

OriginalPaper

Successful co‐treatment with LHRH‐agonist for ovarian over‐stimulation and cystic formation in premenopausal tamoxifen exposure

OriginalPaper

Down‐regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits